Zantac Ranitidine Cancer Lawsuit MDL 2924: What Claimants Need to Know in 2026
A detailed guide to the Zantac (ranitidine) NDMA cancer MDL 2924 in the Southern District of Florida, the 2022 federal dismissal, ongoing Delaware state court litigation, Pfizer settlement reports, and eligibility criteria for claimants.
MDL 2924 Zantac lawsuit ranitidine